Skip to main content

Table 1 Evidence for assessing the suitability of tear proteins for clinical use

From: Practical issues concerning tear protein assays in dry eye

Class of tear protein

Potential clinical marker

Human tear levels show consistent dysregulation

Human tear levels linked to clinical signs/symptoms of dry eye

Change with treatment or severity of dry eye?

Biological function in dry eye pathology known?

Lacrimal protein

Lactoferrin

++++ [21]-[25]

+++ [26],[27]

+ [28]

++ [29]

Protease

MMP-9

+++ [30]-[32]

+++ [11]

+++ [33]

+++ [34]-[42]

Lacrimal protein

Lysozyme

++ [21],[43]-[45]

+ [43]

0

0

Mucins

MUC5AC

+++ [46],[47]

+ [48]

0

++ [49],[50]

Lipid binding protein

Lipocalin

++ [45],[51]

+ [52]

++ [52]

+ [53]-[55]

Interleukines

IL-6

+++ [10],[31],[56],[57]

+ [58]

++ [58]

+ [59]-[61]

Chemokine

IL-8

++ [10],[57],[62],[63]

++ [62]

0

++ [61],[64]

Keratinisation-related

S100A8/9

+++ [5],[13],[14],[65]

+++ [5],[13]

0

+ [66],[67]

Epithelial health

EGF

++ [57],[64],[68]

+ [69]

0

++ [70]

Neurotrophic health

NGF

+++ [71],[72]

++ [71],[73],[74]

++ [73],[74]

++ [75],[76]

  1. ++++ strong evidence.
  2. +++ good evidence.
  3. ++ modest evidence, some uncertainties about implication.
  4. + some evidence but studies may have conflicting results.
  5. 0 no clear evidence.